Free Trial

PharmaCyte Biotech (PMCB) Stock Chart & Stock Price History

PharmaCyte Biotech logo
$1.56 -0.01 (-0.64%)
As of 03/25/2025 04:00 PM Eastern

PharmaCyte Biotech Stock Price Performance

5 Day
Performance
-8.38%
1 Month
Performance
-15.00%
3 Month
Performance
-4.38%
6 Month
Performance
-8.93%
Year-To-Date
Performance
-2.55%
1 Year
Performance
-38.31%
Receive PMCB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter.

PMCB Stock Chart for Wednesday, March, 26, 2025

Remove Ads

PharmaCyte Biotech Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
03/24/2025$1.58$1.57
-0.63%
$1.64$1.4616,848 shs$10.78 million
03/21/2025$1.67$1.58
-5.39%
$1.71$1.5618,874 shs$10.85 million
03/20/2025$1.68$1.67
-0.60%
$1.67$1.634,513 shs$11.47 million
03/19/2025$1.50$1.68
+12.00%
$1.72$1.558,862 shs$11.54 million
03/18/2025$1.58$1.50
-5.06%
$1.73$1.5015,016 shs$10.30 million
03/17/2025$1.58$1.58$1.61$1.581,528 shs$10.85 million
03/14/2025$1.67$1.58
-5.39%
$1.68$1.5225,255 shs$11.01 million
03/13/2025$1.64$1.67
+1.83%
$1.69$1.508,720 shs$11.64 million
03/12/2025$1.76$1.64
-6.82%
$1.76$1.4732,481 shs$11.43 million
03/11/2025$1.78$1.76
-1.12%
$1.76$1.673,904 shs$12.26 million
03/10/2025$1.78$1.78$1.82$1.7612,980 shs$12.40 million
03/07/2025$1.75$1.78
+1.71%
$1.80$1.676,880 shs$12.40 million
03/06/2025$1.79$1.75
-2.23%
$1.76$1.741,460 shs$12.19 million
03/05/2025$1.66$1.79
+7.57%
$1.80$1.7416,311 shs$12.47 million
03/04/2025$1.71$1.66
-2.69%
$1.75$1.578,523 shs$11.60 million
03/03/2025$1.76$1.71
-3.06%
$1.78$1.653,822 shs$11.92 million
02/28/2025$1.75$1.76
+0.80%
$1.84$1.7026,712 shs$12.29 million
02/27/2025$1.72$1.75
+1.74%
$1.75$1.659,664 shs$12.19 million
02/26/2025$1.80$1.72
-4.44%
$1.79$1.689,233 shs$11.99 million
02/25/2025$1.66$1.80
+8.43%
$1.80$1.5712,472 shs$12.54 million
02/24/2025$1.76$1.66
-5.68%
$1.86$1.6610,715 shs$11.57 million

This page (NASDAQ:PMCB) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners